# Safety Study of OPC-12759 Ophthalmic Solution

> **NCT01471093** · PHASE1 · COMPLETED · sponsor: **Otsuka Pharmaceutical Co., Ltd.** · enrollment: 100 (actual)

## Conditions studied

- Dry Eye Syndromes

## Interventions

- **DRUG:** OPC-12759 Ophthalmic solution
- **DRUG:** OPC-12759 Ophthalmic suspension

## Key facts

- **NCT ID:** NCT01471093
- **Lead sponsor:** Otsuka Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2011-12
- **Final completion:** 2012-02
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2021-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01471093

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01471093, "Safety Study of OPC-12759 Ophthalmic Solution". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01471093. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*